Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial

Rafael Cavalcante1,2, MD, PhD; Yoshinobu Onuma1,3, MD, PhD; Yohei Sotomi4, MD; Carlos Collet4, MD; Brian Thomsen5, MSc; Campbell Rogers6, MD; Yaping Zeng1, MD, PhD; Erhan Tenekecioglu1, MD; Taku Asano4, MD; Yosuke Miyasaki1, MD; Mohammad Abdelghani4, MD; Marie-Angèle Morel3, BSc; Patrick W. Serruys1,7*, MD, PhD; on behalf of the SYNTAX III Revolution trial investigators